Shoot - I just wrote a long response to you and my connection got lost and so did the response. I'll recap...
I am sorry for the misunderstanding but I wasn't referring to you as the one being flip. Your questions are very appropriate.
The company's priority is not the website which is just beginning to be developed. There is a url that gets to the research, but I don't know what it is. I'm not sure how you got the idea that the % was people who changed their meds. It fact, it is the % of patients who improved to a CGI-I score of 1 or 2. The initial follow up was for 2 years with the average for the dataset of over 400 days.
Here is a starter list of references (BTW Suffin is currently the Chief Clinical Pathologist for Quest Labs for America and is both a renowned pathologist and in the middle of his career took a residency in psychiatry to develop this database):
1. Suffin SC, Emory WH. Neurometric subgroups in attentional and affective disorders and
their association with pharmacotherapeutic outcome. Clin EEG & Neuro.1995;26:76-83.
2. Prichep LS, Mas F, Hollander E, et al. Quantitative electroencephalographic subtyping of
obsessive compulsive disorder. Psychiat Res: Neuroimaging.1993;Apr;50(1):25-32.
3. Ohashi Y. The baseline EEG traits and the induced EEG changes by antidepressant
medication in patients with major depression. Seishin Shinkeigaku Zasshi.1994;96(6):444-460.
4. Schiller MJ, Emory WH, Suffin SC. rEEG in the treatment of eating disorders. Presented
at NIMHs 44th NCDEU Conference, 2004.
5. Greenblatt J, Sussman C, Jameson M, Kasumova G. Referenced-EEG guided medication
predictions in treatment-refractory eating disorder patients. Presented at APA, 2008.
6. Suffin SC, Emory WH, Gutierrez G, et al. A QEEG database method for predicting
pharmacotherapeutic outcome in refractory major depressive disorders. J of Am
Physicians and Surgeons.2007;12(4):104-108.
7. Schiller MJ, Emory WH, Shaffer J, et al. EEG guidance of psychopharmacologic treatment:
multi-site experience. Presented at APA ,2005.
8. Shaffer JH, Milner JE, Schiller MJ. rEEG guided pharmacotherapy for severely ill dually-
diagnosed patients. Presented at APA, 2005.
9. Schiller MJ. Referenced-EEG guided pharmacotherapy of dually-diagnosed patients.
Presented at College on Problems in Drug Dependence annual meeting, 2008.
In addition you should check on Andrew Leuchter and Ian Cook's work on Cordance (out of UCLA), which is the basis for the BRITE study. They, along with other Harvard authors like Maurizio Fava who was lead author of the STAR*D study and several of is other colleagues are deeply involved with a similar product. Brain Resources out of Australia is internationally known. REEG is getting international attention and is right in the path of the FDA's interest in Personalized Medicine and Biomarkers. This all is part of the new wave of the next movement in Psychiatry and will change the face of how it is practiced.